LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Illinois IL
Legislatures
2025-2026 Regular Session
House
Bills
HB1720
IL
Illinois House Bill HB1720
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Illinois 2025-2026 Regular Session
Illinois House Bill HB1720
Introduced
1/24/25
Refer
1/28/25
Caption
TIANEPTINE PROHIBITION ACT
Latest IL HB1720 Activity
View All Events: IL 2025-2026 Regular Session HB1720
Companion Bills
No companion bills found.
Previously Filed As
IL HB4628
CONTROL SUB-TIANEPTINE-SCH III
IL HB3761
INS-PBM/DUTIES & PROHIBITIONS
IL SB0647
HEALTH-TECH
IL SB1721
HEARING INSTRUMENT ACT-VARIOUS
IL HB3112
TOBACCO PRODUCTS-RATE
IL HB4989
TOBACCO POSSESS
IL SB3926
HEMP CONSUMER PRODUCTS ACT
IL HB4211
CANNABIS-CONSOLIDATE TRANSPORT
IL HB4150
ASSAULT WEAPONS - AFFIDAVIT
IL SB3695
ILLINOIS CURE ACT
Similar Bills
IL HB3168
TIANEPTINE-RETAIL SALE PROHIB
IL HB4628
CONTROL SUB-TIANEPTINE-SCH III
MS HB838
Mississippi Tianeptine and Kratom Consumer Protection Act; create.
MD HB1230
Public Health - Tianeptine Consumer Protection Act
NJ S3668
Establishes tianeptine as Schedule II controlled dangerous substance.
NJ S729
Establishes tianeptine as Schedule II controlled dangerous substance.
NJ A4814
Establishes tianeptine as Schedule II controlled dangerous substance.
CA AB2217
Tianeptine.